Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study (2022)
Attributed to:
An Injectable Implant Providing Long-Acting Drug Delivery for the Treatment of Chronic disease
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/22221751.2022.2117092
Publication URI: http://dx.doi.org/10.1080/22221751.2022.2117092
Type: Journal Article/Review
Parent Publication: Emerging Microbes & Infections
Issue: 1